Immupharma (IMM)

 

Latest News

Holding(s) in Company

RNS Number: 8466E Immupharma PLC 21 July 2016 RNS: FOR IMMEDIATE RELEASE 21 JULY 2016 ImmuPharma PLC ("ImmuPharma" or the "Company") TR1 NOTIFICATION OF MAJOR INTEREST BY AVIVA ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, announces that it has received a TR-1 by Aviva plc ("A...

Broker Forecast - Northland Capital issues a broker note on ImmuPharma PLC

Northland Capital today initiates coverage of ImmuPharma PLC (LON:IMM) with a buy investment rating and price targ...

Holding(s) in Company

RNS Number: 0441D Immupharma PLC 01 July 2016 RNS: FOR IMMEDIATE RELEASE 1 JULY 2016 ImmuPharma PLC ("ImmuPharma" or the "Company") TR1 NOTIFICATION OF MAJOR INTEREST BY AVIVA ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, announces that it has today received a TR-1 by Aviva p...

Second Price Monitoring Extn

RNS Number: 4019C Immupharma PLC 27 June 2016 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined percen...

All News

DateHeadlineSource
21-07-16Holding(s) in CompanyRNS
20-07-16Broker Forecast - Northland Capital issues a broker note on ImmuPharma PLCStockMarketWire
01-07-16Holding(s) in CompanyRNS
27-06-16Second Price Monitoring ExtnRNS
27-06-16Price Monitoring ExtensionRNS
20-06-16ImmuPharma appoints joint broker StockMarketWire
20-06-16Appointment of Joint BrokerRNS
09-06-16Why are Immupharma plc, Purplebricks Group plc and Roxi Petroleum plc among today’s major movers?Motley Fool
09-06-16Holding(s) in CompanyRNS
08-06-16Symposium with Lupuzors Inventor Prof. S MullerRNS
07-06-16ImmuPharma update on Lupuzor studyStockMarketWire
07-06-16Are Synairgen plc or Immupharma plc better investments than AstraZeneca plc?Motley Fool
07-06-16European Patients Commence Dosing in LupuzorRNS
02-06-16Director/PDMR ShareholdingRNS
31-05-16Holding(s) in CompanyRNS
26-05-16ImmuPharma resolutions passed at AGMStockMarketWire
26-05-16Result of AGMRNS
25-05-16Holding(s) in CompanyRNS
04-05-16ImmuPharma losses widenStockMarketWire
04-05-16Annual Financial Report & Notice of AGMRNS
04-05-16Final ResultsRNS
26-04-16ImmuPharma schedules FY results StockMarketWire
26-04-16Notice of ResultsRNS
22-04-16Holding(s) in CompanyRNS
09-03-16ImmuPharma starts European patient recruitment for Lupuzor trial StockMarketWire
09-03-16First European Site Opens - Patient RecruitmentRNS
08-03-16Holding(s) in CompanyRNS
07-03-16Holding(s) in CompanyRNS
01-03-16EIS and VCT Qualifying Status and Issue of EquityRNS
29-02-16Holding(s) in CompanyRNS
24-02-16ImmuPharma raises GBP7.7mStockMarketWire
24-02-16Issue of EquityRNS
22-02-16ImmuPharma fundraising approved StockMarketWire
22-02-16Result of GMRNS
15-02-16Dosing starts for ImmuPharma's Lupuzor trial StockMarketWire
15-02-16US PATIENTS COMMENCE DOSING IN PHASE III STUDYRNS
05-02-16ImmuPharma raises GBP8.3m via placingStockMarketWire
05-02-16Placing and Subscription Raises £8.3 millionRNS
05-02-16ImmuPharma fundraising to finance Lupuzor trial StockMarketWire
05-02-16Proposed Placing and SubscriptionRNS

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory